| Financial Year |
March 31 2023 |
| Monetary Funds |
607,332,767.79 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
31,650,631.32 |
| Accounts Receivable |
763,200,825.44 |
| Advances to Suppliers |
39,407,899.17 |
| Other Receivables |
29,426,643.14 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
884,455,335.31 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
38,106,105.36 |
| Total Current Assets |
2,407,807,966.83 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
113,060,225.13 |
| Investment Properties |
-- |
| Fixed Assetes |
847,811,801.97 |
| Under-construction Projects |
113,447,812.97 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
142,812,369.57 |
| R&D expenses |
-- |
| Goodwill |
6,168,749.24 |
| Long-Term Deferred and Prepaid Expenses |
47,964,597.07 |
| Deferred Income Tax Assets |
25,089,336.29 |
| Other Non-Current Assets |
284,835,369.51 |
| Sub-Total of Non-Current Assets |
1,661,440,694.12 |
| Total Assets |
4,069,248,660.95 |
| Short-Term Loans |
269,462,640.55 |
| Trading Financial liabilities |
1,420,528.52 |
| Notes Payable |
111,559,129.98 |
| Accounts Payable |
368,089,212.23 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
39,162,055.55 |
| Taxes Payable |
27,055,844.95 |
| Interest Payable |
428,952.10 |
| Dividend Payable |
-- |
| Other payables |
166,394,552.81 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
256,555,237.19 |
| Other Current Liabilities |
37,260,735.44 |
| Sub-Total of Current Liabilities |
1,346,119,386.26 |
| Long-term Loans |
569,734,309.74 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,842,160.35 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
659,579,070.83 |
| Total Liabilities |
2,005,698,457.09 |
| Paid-In Capital(Or Share Stock) |
650,859,649.00 |
| Capital Surplus |
398,101,666.25 |
| Surplus Reserve |
112,495,058.54 |
| LESS:Treasury Stock |
29,996,193.51 |
| Undistributed Profits |
771,359,397.21 |
| Minority Stockholder's Interest |
226,946,826.50 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,836,603,377.36 |
| Owner's Equity（Stockholder's Equity） |
2,063,550,203.86 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,069,248,660.95 |
